President's Cancer Panel

The Panel accomplishes its mission by identifying high-priority topics for which actionable recommendations can be made, convening meetings with key experts and stakeholders to develop an understanding of the problems, challenges, opportunities, and potential solutions and then framing possible recommendations, including actions that should be taken by relevant organizations. Ultimately, following substantial input, the Panel submits a report to the President of the United States.

The Panel communicates its findings using a variety of tools—including print and web-based reports, social media, and presentations to a range of organizations. While reports are to the President, they are also for the larger group of stakeholders, public and private, that form the National Cancer Program as well as other partner organizations. Together, these organizations and others can make a positive difference in accelerating progress against cancer.

National Cancer Program

The Panel was established as part of The National Cancer Act of 1971 (P.L. 92-218). The Act strengthened the national effort against cancer and was signed into law by President Nixon on December 23, 1971. The Panel is a Federal Advisory Committee governed by FACA (Federal Advisory Committee Act of 1972 [P.L. 92-463]) and is supported by the National Cancer Institute. A summary of the Panel’s charter can be accessed here.